Kanaly Trust’s Emergent Biosolutions EBS Stock Holding History

Kanaly Trust’s Portfolio EBS Stock Details EBS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q4	–	Sell	-92	Closed	-$2K	–	739
2014 Q3	$2K	Buy	+92	New	+$2.11K	﹤0.01%	698

Other funds holding EBS

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

FMA

Fiduciary Management Associates Chicago, Illinois $1.53B AUM 4.47% 1-Year Est. Return

Guggenheim Capital Chicago, Illinois $12.9B AUM 27.3% 1-Year Est. Return

Kanaly Trust's EBS Position: Q4 2014 in Review

Kanaly Trust sold out of Emergent Biosolutions (EBS) in Q4 2014, closing a stake of 92 shares — an estimated $2K sold.

Kanaly Trust first reported a position in EBS in Q3 2014 and held it in 1 quarter. The position peaked at $2K in Q3 2014. 167 funds tracked by Wall St. Rank hold EBS as of Q4 2014.

Kanaly Trust reported no remaining Emergent Biosolutions position as of Q4 2014 after selling out during the quarter.
Kanaly Trust sold 92 Emergent Biosolutions shares in Q4 2014, an estimated $2K.
Kanaly Trust first reported a position in Emergent Biosolutions in Q3 2014 and held it in 1 quarter.
Kanaly Trust's Emergent Biosolutions position peaked at $2K in Q3 2014.
167 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q4 2014.

Based on Kanaly Trust's 13F filing for Q4 2014, filed 26 Jan 2015.